Nicholas D. Walter

Nicholas D. Walter

Auto-generated profile, based on publicly available information

Nicholas D. Walter

Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Anschutz Medical Campus

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
NWNicholas D. Walter
Nicholas D. Walter
SBSarah E. M. Born
Sarah E. M. Born
GRGregory T. Robertson
Gregory T. Robertson
MRMatthew Reichlen
Matthew Reichlen
CDChristian Dide-Agossou
Christian Dide-Agossou
MVMartin I. Voskuil
Martin I. Voskuil
There is urgent need for new drug regimens that more rapidly cure tuberculosis (TB). Existing TB drugs and regimens vary in treatment-shortening activity, but the molecular basis of these differences is unclear, and no existing assay directly quantifies the ability of a drug or regimen to shorten treatment. Here, we show that drugs historically classified as sterilizing and non-sterilizing have distinct impacts on a fundamental aspect of Mycobacterium tuberculosis physiology: ribosomal RNA (rRNA) synthesis. In culture, in mice, and in human studies, measurement of precursor rRNA reveals that sterilizing drugs and highly effective drug regimens profoundly suppress M. tuberculosis rRNA synthesis, whereas non-sterilizing drugs and weaker regimens do not. The rRNA synthesis ratio provides a readout of drug effect that is orthogonal to traditional measures of bacterial burden. We propose that this metric of drug activity may accelerate the development of shorter TB regimens.

11 March 2015 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
NWNicholas D. Walter
Nicholas D. Walter
GDGregory M. Dolganov
Gregory M. Dolganov
BGBenjamin J. Garcia
Benjamin J. Garcia
WWWilliam Worodria
William Worodria
AAAlfred Andama
Alfred Andama
JDJ. Lucian Davis
J. Lucian Davis
Background. Treatment initiation rapidly kills most drug-susceptible Mycobacterium tuberculosis, but a bacterial subpopulation tolerates prolonged drug exposure. We evaluated drug-tolerant bacilli in human sputum by comparing messenger RNA (mRNA) expression of drug-tolerant bacilli that survive the early bactericidal phase with treatment-naive bacilli. Methods. M. tuberculosis gene expression was quantified via reverse-transcription polymerase chain reaction in serial sputa from 17 Ugandans treated for drug-susceptible pulmonary tuberculosis. Results. Within 4 days, bacterial mRNA abundance declined >98%, indicating rapid killing. Thereafter, the rate of decline slowed >94%, indicating drug tolerance. After 14 days, 16S ribosomal RNA transcripts/genome declined 96%, indicating slow growth. Drug-tolerant bacilli displayed marked downregulation of genes associated with growth, metabolism, and lipid synthesis and upregulation in stress responses and key regulatory categories—including stress-associated sigma factors, transcription factors, and toxin-antitoxin genes. Drug efflux pumps were upregulated. The isoniazid stress signature was induced by initial drug exposure, then disappeared after 4 days. Conclusions. Transcriptional patterns suggest that drug-tolerant bacilli in sputum are in a slow-growing, metabolically and synthetically downregulated state. Absence of the isoniazid stress signature in drug-tolerant bacilli indicates that physiological state influences drug responsiveness in vivo. These results identify novel drug targets that should aid in development of novel shorter tuberculosis treatment regimens.

15 January 2010 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
NWNicholas D. Walter
Nicholas D. Walter
TTThomas H. Taylor
Thomas H. Taylor
DSDavid K. Shay
David K. Shay
WTWilliam W. Thompson
William W. Thompson
LBLynnette Brammer
Lynnette Brammer
MMMatthew R. Moore
Matthew R. Moore
Background. Animal models and data from influenza pandemics suggest that influenza infection predisposes individuals to pneumococcal pneumonia. Influen

1 January 2014 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
NWNicholas D. Walter
Nicholas D. Walter
JPJohn Painter
John Painter
MPMatthew Parker
Matthew Parker
PLPhillip Lowenthal
Phillip Lowenthal
JFJennifer Flood
Jennifer Flood
FCfor the Tuberculosis Epidemiologic Studies Consortium
for the Tuberculosis Epidemiologic Studies Consortium
Rationale: Current guidelines limit latent tuberculosis infection (LTBI) evaluation to persons in the United States less than or equal to 5 years based on the assumption that high TB rates among recent entrants are attributable to high LTBI reactivation risk, which declines over time. We hypothesized that high postarrival TB rates may instead be caused by imported active TB. Objectives: Estimate reactivation and imported TB in an immigrant cohort. Methods: We linked preimmigration records from a cohort of California-bound Filipino immigrants during 2001–2010 with subsequent TB reports. TB was likely LTBI reactivation if the immigrant had no evidence of active TB at preimmigration examination, likely imported if preimmigration radiograph was abnormal and TB was reported less than or equal to 6 months after arrival, and likely reactivation of inactive TB if radiograph was abnormal but TB was reported more than 6 months after arrival. Measurements and Main Results: Among 123,114 immigrants, 793 TB cases were reported. Within 1 year of preimmigration examination, 85% of TB was imported; 6 and 9% were reactivation of LTBI and inactive TB, respectively. Conversely, during Years 2–9 after U.S. entry, 76 and 24% were reactivation of LTBI and inactive TB, respectively. The rate of LTBI reactivation (32 per 100,000) did not decline during Years 1–9. Conclusions: High postarrival TB rates were caused by detection of imported TB through active postarrival surveillance. Among immigrants without active TB at baseline, reported TB did not decline over 9 years, indicating sustained high risk of LTBI reactivation. Revised guidelines should support LTBI screening and treatment more than 5 years after U.S. arrival.

1 February 2016 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
NWNicholas D. Walter
Nicholas D. Walter
MMMikaela A. Miller
Mikaela A. Miller
JVJoshua Vasquez
Joshua Vasquez
MWMarc Weiner
Marc Weiner
ACAdam Chapman
Adam Chapman
MGMark W. Geraci
Mark W. Geraci
Blood transcriptional signatures are promising for tuberculosis (TB) diagnosis but have not been evaluated among U.S. patients. To be used clinically, transcriptional classifiers need reproducible accuracy in diverse populations that vary in genetic composition, disease spectrum and severity, and comorbidities. In a prospective case-control study, we identified novel transcriptional classifiers for active TB among U.S. patients and systematically compared their accuracy to classifiers from published studies. Blood samples from HIV-uninfected U.S. adults with active TB, pneumonia, or latent TB infection underwent whole-transcriptome microarray. We used support vector machines to classify disease state based on transcriptional patterns. We externally validated our classifiers using data from sub-Saharan African cohorts and evaluated previously published transcriptional classifiers in our population. Our classifier distinguishing active TB from pneumonia had an area under the concentration-time curve (AUC) of 96.5% (95.4% to 97.6%) among U.S. patients, but the AUC was lower (90.6% [89.6% to 91.7%]) in HIV-uninfected Sub-Saharan Africans. Previously published comparable classifiers had AUC values of 90.0% (87.7% to 92.3%) and 82.9% (80.8% to 85.1%) when tested in U.S. patients. Our classifier distinguishing active TB from latent TB had AUC values of 95.9% (95.2% to 96.6%) among U.S. patients and 95.3% (94.7% to 96.0%) among Sub-Saharan Africans. Previously published comparable classifiers had AUC values of 98.0% (97.4% to 98.7%) and 94.8% (92.9% to 96.8%) when tested in U.S. patients. Blood transcriptional classifiers accurately detected active TB among U.S. adults. The accuracy of classifiers for active TB versus that of other diseases decreased when tested in new populations with different disease controls, suggesting additional studies are required to enhance generalizability. Classifiers that distinguish active TB from latent TB are accurate and generalizable across populations and can be explored as screening assays.

24 December 2009 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
NWNicholas D. Walter
Nicholas D. Walter
TTThomas H. Jr. Taylor
Thomas H. Jr. Taylor
SDScott F. Dowell
Scott F. Dowell
SMSaundra Mathis
Saundra Mathis
MMMatthew R. Moore
Matthew R. Moore
Rates of invasive pneumococcal disease in the United States increase dramatically, or “spike,” during winter holidays.1 We analyzed population-based surveillance data to determine whether spikes may be caused by increased transmission from children to older adults.